Press release
United Therapeutics Corporation to Present at Upcoming Investor Conferences
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced
About this update from United Therapeutics Corporation
[{"type":"text","content":" SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--\nUnited Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that company executives will provide an overview and update on the company during fireside chat sessions at two upcoming investor conferences.\n\n\nPatrick Poisson, Executive Vice President, Strategic Development, will present at the UBS Global Healthcare Conference in Palm Beach, Florida on Monday, November 10, 2025, from 9:30 a.m. to 10:05 a.m., Eastern Standard Time.\n\n\nJames Edgemond, Chief Financial Officer and Treasurer, will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025, from 12:00 p.m. to 12:25 p.m., Greenwich Mean Time.\n\n\nThe sessions can be accessed via a live webcast on the United Therapeutics website at https://ir.unither.com/events-and-presentations. Archived, recorded versions of the sessions will be available approximately 24 hours after each session ends and can be accessed for 90 days.\n\n\nUnited Therapeutics: Enabling Inspiration\n\n\nAt United Therapeutics, our vision and mission are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good. We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC). Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical therapies; and (b) technologies that expand the availability of transplantable organs.\n\n\nYou can learn more about what it means to be a PBC here: unither.com/pbc.\n\n\nForward-Looking Statements\n\n\nStatements included in this press release that are not historical in nature are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, among others, our efforts to innovate for the unmet medical needs of our patients, to benefit our other stakeholders, and to pursue our public benefit purpose of developing novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. These forward-looking statements are subject to certain risks and uncertainties,...